Search hospitals > California > Fresno
Fresno Cancer Center
Claim this profileFresno, California 93720
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Prostate Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
81 reported clinical trials
6 medical researchers
Summary
Fresno Cancer Center is a medical facility located in Fresno, California. This center is recognized for care of Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Adenocarcinoma and other specialties. Fresno Cancer Center is involved with conducting 81 clinical trials across 145 conditions. There are 6 research doctors associated with this hospital, such as Jennifer M. Suga, Samantha A. Seaward, Tatjana Kolevska, MD, and Ramey D. Littell.Area of expertise
1Cancer
Global LeaderStage III
p16 positive
Stage IV
2Breast Cancer
Global LeaderStage I
Stage II
Stage III
Top PIs
Jennifer M. SugaKaiser Permanente-Oakland1 year of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
34 reported clinical trials
98 drugs studied
Samantha A. SeawardKaiser Permanente Medical Center - Santa Clara2 years of reported clinical research
Studies Cancer
Studies Breast Cancer
22 reported clinical trials
63 drugs studied
Tatjana Kolevska, MDKaiser Permanente-Vallejo7 years of reported clinical research
Studies Skin Cancer
Studies Cutaneous Melanoma
21 reported clinical trials
51 drugs studied
Ramey D. LittellKaiser Permanente-Roseville4 years of reported clinical research
Studies Ovarian Cancer
Studies Adenocarcinoma
5 reported clinical trials
13 drugs studied
Clinical Trials running at Fresno Cancer Center
Breast Cancer
Prostate Cancer
Melanoma
Cutaneous Melanoma
Ovarian Cancer
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Squamous Cell Carcinoma
Liposarcoma
Fallopian Tube Cancer
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Fresno Cancer Center?
Fresno Cancer Center is a medical facility located in Fresno, California. This center is recognized for care of Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Adenocarcinoma and other specialties. Fresno Cancer Center is involved with conducting 81 clinical trials across 145 conditions. There are 6 research doctors associated with this hospital, such as Jennifer M. Suga, Samantha A. Seaward, Tatjana Kolevska, MD, and Ramey D. Littell.